Jordi Camps

Research group

Translational colorectal cancer genomics Junior group leader (R3B)

jcamps@recerca.clinic.cat 0000-0003-2929-4228

Featured publications

Centrosome reduction in newly-generated tetraploid cancer cells obtained by separase depletion

Authors:
Galofre, Claudia; Asensio, Elena; Ubach, Maria; Torres, Irianna M; Quintanilla, Isabel;

Castells, Antoni; Camps, Jordi.

Reference: Scientific Reports 2020.
Tetraploidy-Associated Genetic Heterogeneity Confers Chemo-Radiotherapy Resistance to Colorectal Cancer Cells

Authors:
Galofré C; Gönül Geyik Ö; Asensio E; Wangsa D; Hirsch D;

(...)

Mollà M; Yüce Z; Castells A; Ried T; Camps J .

Reference: Cancers 2020.
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications

Authors:
Franch-Exposito, Sebastia; Bassaganyas, Laia; Vila-Casadesus, Maria; Hernandez-Illan, Eva; Esteban-Fabro, Roger;

(...)

Jose Lozano, Juan; Castells, Antoni; Maria Llovet, Josep; Castellvi-Bel, Sergi; Camps, Jordi.

Reference: Elife 2020.
The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome

Authors:
Ried T; Meijer GA; Harrison DJ; Grech G; Franch-Expósito S;

Briffa R; Carvalho B; Camps J .

Reference: Molecular Aspects Of Medicine 2019.
Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells

Authors:
Wangsa, Darawalee; Braun, Rudiger; Stuelten, Christina H; Brown, Markus; Bauer, Kerry M;

(...)

Warner, Lidia; Upender, Madhvi; Hummon, Amanda B; Camps, Jordi; Ried, Thomas.

Reference: Neoplasia 2019.
The non-random landscape of somatically-acquired uniparental disomy in cancer

Authors:
Erola P; Torabi K; Miró R; Camps J;

Reference: Oncotarget 2019.
Quantitative analysis of somatically-acquired and constitutive uniparental disomy in gastrointestinal cancers

Authors:
Torabi, Keyvan; Erola, Pau; Isabel Alvarez-Mora, Maria; Diaz-Gay, Marcos; Ferrer, Queralt;

(...)

Jose Lozano, Juan; Miro, Rosa; Ried, Thomas; Ponsa, Immaculada; Camps, Jordi.

Reference: International Journal Of Cancer 2019.
Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.

Authors:
Wangsa, Darawalee; Quintanilla, Isabel; Torabi, Keyvan; Vila-Casadesus, Maria; Ercilla, Amaia;

(...)

Agell, Neus; Cimini, Daniela; Castells, Antoni; Ried, Thomas; Camps, Jordi.

Reference: Faseb Journal 2018.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Authors:
Codony-Servat, Jordi; Cuatrecasas, Miriam; Asensio, Elena; Montironi, Carla; Martinez-Cardus, Anna;

(...)

Prat, Aleix; Rosell, Rafael; Garcia-Albeniz, Xabier; Camps, Jordi; Maurel, Joan.

Reference: British Journal Of Cancer 2017.
Transcription-dependent radial distribution of TCF7L2 regulated genes in chromosome territories

Authors:
Torabi, Keyvan; Wangsa, Darawalee; Ponsa, Immaculada; Brown, Markus; Bosch, Anna;

(...)

Calvo, Maria; Castells, Antoni; Miro, Rosa; Ried, Thomas; Camps, Jordi.

Reference: Chromosoma 2017.

Featured Projects

Spatial distribution of genomic alterations in tumor buds and poorly differentiated clusters of colorectal cancer and their role in tumor immune evasion and metastasis

Principal investigator: Miriam Cuatrecasas Freixas, Jordi Camps Polo

Funder: Instituto de Salud Carlos III

Code: PI20/00863

Duration: 01/01/2021 - 31/12/2023
Nuevas estrategias para la estratificación del riesgo de recidiva en pacientes con cáncer de colon en estadio II: Integración de perfiles genómicos y carga tumoral ganglionar

Principal investigator: Miriam Cuatrecasas Freixas, Jordi Camps Polo

Funder: Instituto de Salud Carlos III

Code: PI17/01304

Duration: 01/01/2018 - 30/06/2022
Implicaciones de la heterogeneidad intratumoral en la respuesta al tratamiento de quimio-radioterapia neoadyuvante en pacientes con cáncer de recto

Principal investigator: Jordi Camps Polo

Funder: Instituto de Salud Carlos III

Code: FIS14 PI14/00783

Duration: 01/01/2015 - 01/01/2017
Identification of genetic determinants for the progression and response to treatment of colorectal cancer

Principal investigator: Jordi Camps Polo

Funder: Instituto de Salud Carlos III

Duration: 01/01/2014 - 01/01/2016
Implications of copy number variants of the genome in the etiology and progression of colorectal cancer

Principal investigator: Jordi Camps Polo

Funder: European Comission

Code: CE-FP7-PPLE-2012-CIG

Duration: 01/01/2013 - 01/01/2017

Jordi Camps

Research group

Featured publications

Featured Projects

Spatial distribution of genomic alterations in tumor buds and poorly differentiated clusters of colorectal cancer and their role in tumor immune evasion and metastasis

Nuevas estrategias para la estratificación del riesgo de recidiva en pacientes con cáncer de colon en estadio II: Integración de perfiles genómicos y carga tumoral ganglionar

Implicaciones de la heterogeneidad intratumoral en la respuesta al tratamiento de quimio-radioterapia neoadyuvante en pacientes con cáncer de recto

Identification of genetic determinants for the progression and response to treatment of colorectal cancer

Implications of copy number variants of the genome in the etiology and progression of colorectal cancer

Subscribe to the Newsletter of Clínic